Risk of second primary cancers after testicular cancer in East and West Germany: a focus on contralateral testicular cancers.

Testicular cancer survival rates improved dramatically after cisplatin-based therapy was introduced in the 1970s. However, chemotherapy and radiation therapy are potentially carcinogenic. The purpose of this study was to estimate the risk of developing second primary cancers including the risk associated with primary histologic type (seminoma and non-seminoma) among testicular cancer survivors in Germany.

Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany.

Aim: To study the epidemiologic changes of gastroenteropancreatic neuroendocrine tumors (GEP-NET) in Germany, we analyzed two time periods 1976-1988 and 1998-2006.

Methods: We evaluated epidemiological data of GEP-NET from the former East German National Cancer Registry (DDR Krebsregister, 1976-1988) and its successor, the Joint Cancer Registry (GKR, 1998-2006), which was founded after German reunification. Due to a particularly substantial database the epidemiological data from the federal states of Mecklenburg-Western Pomerania, Saxony, Brandenburg and Thuringia, covering a population of more than 10.

Incidence of skin lymphoma in Germany.

Purpose: Population-based analyses of the incidence of skin lymphoma in Europe are very sparse. We analyzed German population-based incidence data on skin lymphoma to study the descriptive epidemiology of these tumors.

Methods: We extracted skin lymphoma cases from the registry files of the East German National Cancer Registry (1976-1989) and registries of three new federal states (1998-2002) (Sachsen, Brandenburg, Mecklenburg-Vorpommern), the Cancer Registry Schleswig-Holstein, Lübeck (1998-2002), and the Epidemiological Cancer Registry Münster (1998-2002).

Population-based incidence rates of malignant melanoma of the vulva in Germany.

Objectives: Only few population-based incidence analyses of vulvar melanoma including the United States and Sweden are currently available. We studied the incidence of vulvar melanoma in a large population-based cancer registry of East Germany and compared our findings with the United States and Sweden.

Methods: We extracted vulvar melanoma registered between 1976 and 1989 in the former National Cancer Registry of the German Democratic Republic (GDR) and of three new East German cancer registries of the federal states of Sachsen, Brandenburg, and Mecklenburg-Vorpommern of the period 1998 to 2002.

[The importance of the common cancer registry for the identification of cancer cases in the EPIC Potsdam-study -- results of the first record linkage].

Aim: The follow-up of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study has been identifying cancer diagnoses by an active follow-up through participant's self-report which is then confirmed by pathology registries or medical doctors. To utilise another source of information, a record linkage was performed with the Common Cancer Registry (CCR) of the states of Berlin, Brandenburg, Mecklenburg-Western Pomerania, Saxony-Anhalt and of the free states Saxony and Thuringia in November 2001, using the EPIC-Potsdam database of compliant study participants at that point in time (n = 27 087). This methodological study compares data of identified cancer cases in the EPIC-Potsdam study with those generated through the record linkage.